Charles N York Ii is COO, CFO AND SECRETARY of Day One Biopharmaceuticals, Inc.. Currently has a direct ownership of 224,868 shares of DAWN, which is worth approximately $2.98 Million. The most recent transaction as insider was on Aug 15, 2022, when has been sold 4,125 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 225K
19.04% 3M change
15.08% 12M change
Total Value Held $2.98 Million

Charles N York II Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 15 2022
BUY
Exercise of conversion of derivative security
-
4,125 Added 1.25%
325,490 Common Stock
Aug 04 2022
SELL
Open market or private sale
$200,500 $20.05 p/Share
10,000 Reduced 3.02%
321,365 Common Stock
Jul 18 2022
SELL
Open market or private sale
$50,000 $20.0 p/Share
2,500 Reduced 0.75%
331,365 Common Stock
Jul 08 2022
SELL
Open market or private sale
$28,320 $20.0 p/Share
1,416 Reduced 0.42%
333,865 Common Stock
Jul 05 2022
SELL
Open market or private sale
$16,000 $20.0 p/Share
800 Reduced 0.24%
335,281 Common Stock
Jul 01 2022
SELL
Open market or private sale
$29,580 $20.0 p/Share
1,479 Reduced 0.44%
336,081 Common Stock
CNY

Charles N York Ii

COO, CFO AND SECRETARY
South San Francisco, CA

Track Institutional and Insider Activities on DAWN

Follow Day One Biopharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DAWN shares.

Notify only if

Insider Trading

Get notified when an Day One Biopharmaceuticals, Inc. insider buys or sells DAWN shares.

Notify only if

News

Receive news related to Day One Biopharmaceuticals, Inc.

Track Activities on DAWN